Strategic sale results in a CDMO-focused company aligned with attractive growth categories and end markets Net proceeds from the saleRead More…
Landec Corporation Reports First Quarter Fiscal Year 2022 Results
Quarterly net loss of $9.5 million, EBITDA of $1.1 million, and Adjusted EBITDA of $4.4 million Reiterates Fiscal Year 2022 Guidance SANTA MARIA,Read More…
Landec Corporation Sets First Quarter 2022 Earnings Conference Call for September 29, 2021 at 2 p.m. PT
SANTA MARIA, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) — Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Lifecore Biomedical,Read More…
Landec Corporation Reports Fourth Quarter and Full Fiscal Year 2021 Results
Lifecore Biomedical Generates Full Year Revenue Growth of 14.3%, Net Income Growth of 23.1%, and Adjusted EBITDA Growth of 22.0%Read More…
Landec Corporation Sets Fourth Quarter 2021 Earnings Conference Call for July 28, 2021 at 2 p.m. PT
SANTA MARIA, Calif., July 14, 2021 (GLOBE NEWSWIRE) — Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Lifecore Biomedical,Read More…
Landec Sells Investment in Windset Holdings
Early sale to affiliates of founding and controlling investors for $45.1 million Net proceeds to be used to repay a portionRead More…
Lifecore to Manufacture New Innovative Drug for Treatment of Postoperative Pain Following Customer’s FDA Approval
Lifecore Expands its Aseptic Production of Pharmaceutical Drugs CHASKA, Minn., May 17, 2021 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc., a fully-owned subsidiary of LandecRead More…
Landec Enters into Transportation Management, Warehousing, and Transportation Services Agreement with Castellini Company LLC
A continuation of Project SWIFT, Agreement seeks to improve Curation Foods’ market reach while further simplifying operations, including facility rationalizationSANTARead More…
Landec Corporation Reports Third Quarter and First Nine Months Fiscal 2021 Results
Lifecore Biomedical Generates Year-to-date Revenue Growth of 20%, Net Income Growth of 39%, and Adjusted EBITDA Growth of 34% ReiteratesRead More…
Landec Corporation Sets Third Quarter 2021 Earnings Conference Call for April 7, 2021 at 2 p.m. PT
SANTA MARIA, Calif., March 23, 2021 (GLOBE NEWSWIRE) — Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Lifecore Biomedical,Read More…